Lok Sabha Question No. 1030 (UNSTARRED), answered on 2021-12-03
Subject: Use of AYUSH Drugs
Ministry: AYURVEDA,YOGA & NATUROPATHY,UNANI,SIDDHA AND HOMEOPATHY (AYUSH)
Asked by: Rajbahadur Singh, Jayadev Galla, Krishna Pal Singh Yadav, P.P. Chaudhary, Pratap Chandra Sarangi

## GOVERNMENT OF INDIA MINISTRY OF AYURVEDA, YOGA & NATUROPATHY, UNANI, SIDDHA AND HOMOEOPATHY

## LOK SABHA UNSTARRED QUESTION NO. 1030 TO BE ANSWERED ON 03 rd  DECEMBER, 2021

## USE OF AYUSH DRUGS

1030. SH. RAJBAHADUR SINGH SH. JAYADEV GALLA, DR. KRISHNA PAL SINGH YADAV, SH. P. P. CHAUDHARY SH. PRATAP CHANDRA SARANGI

Will the Minister of AYUSH be pleased to state:

- (a) whether  the  use  of  AYUSH  medicines  like  AYUSH-64  was  made  to  treat patients with milder symptoms;
- (b) if so, the details of those administered the said medicines and thus cured;
- (c) whether the  Government has put forward  the  same for  international  clinical trials and further get usage approvals abroad and if so, the details and the outcome thereof;
- (d) the  number  of  professionals  trained  and  employed  State/UT-wise  during COVID under the National AYUSH Mission; and
- (e) the  number  of  patients  addressed  through  use  of  tele-medicine  under  the National AYUSH Mission for the last three years?

## ANSWER

## THE MINISTER OF AYUSH IN THE MINISTRY OF AYURVEDA, YOGA & NATUROPATHY, UNANI, SIDDHA AND HOMOEOPATHY (SHRI SARBANANDA SONOWAL)

- (a) Yes, Sir.
- (b) AYUSH Medicines viz AYUSH -64 and KabasurKudineer were administered to COVID-19 asymptomatic and mild to moderate patients during a campaign launched  by  Ministry  of  Ayush.  A  total  of  63,265  patients  got  benefit  from these  medicines.  The  outcomes  of  these  interventions  showed  significant improvement  in  clinical  recovery  and  duration  of  hospital  stay  without  any progression  of  the  disease  to  severe  or  critical  stage.  Also,  there  was improvement in Quality of life (QoL) parameters. These interventions found to be well tolerated and safe.
- (c) Yes,  Sir.  Ministry  of  Ayush,  through  its  Autonomous  Institute  i.e.  All  India Institute of Ayurveda (AIIA), New Delhi has signed an agreement with London School  of  Hygiene  &  Tropical  Medicine  (LSH&TM),  UK  for  conducting  the study on 'Ashwagandha for promoting recovery from Covid-19 in the UK' on 22  July  2021.  The  study  is  a  Randomized,  placebo  controlled  double  blind trial. The study has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) and certified by WHO-GMP. It is being conducted and  monitored  as  per  the  internationally  recognized  GCP  (Good  Clinical Practices)  guidelines.  All  India  Institute  of  Ayurveda  (AIIA),  New  Delhi  has also signed an agreement with Frankfurter InnovationszentrumBiotechnologie GmbH (FIZ), Frankfurt, Germany on 15.06.2021 for conducting Collaborative Research study entitled 'Understanding the molecular mechanism of Guduchyadi tablets in combating COVID-19 infection- In-vitro & in-vivo study'.
- (d) Ministry  of  AYUSH  and  Ministry  of  Health  and  Family  Welfare  have  jointly provided training to 33,000 AYUSH master trainers. A total of 66045 AYUSH

Personnel had obtained training at igot.in platform on continual basis. Ministry of  AYUSH  has  coordinated  with  Ministry  of  Health  and  Family  Welfare  for utilization  of  AYUSH  manpower  as  COVID  warrior  for  the  management  of Covid-19 with identified roles.

- (e) As per the proposals received from different State / UT Governments through State Annual Action Plans (SAAPs) under National Ayush Mission (NAM), 03 proposals of tele-medicines have been approved in the States of Bihar, Uttar Pradesh  &  Telangana  during  last  three  years.  However,  implementation comes under the purview of State/ UT Governments.